Novocure Ltd (NASDAQ:NVCR)
| 164.62 Delayed Data As of Jan 26 |  -2.64 / -1.58%Today’s Change | 53.40 Today|||52-Week Range 182.74 | -4.87% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $17.2B |
Company Description
NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
Contact Information
Novocure Ltd. No. 4 The Forum St. Helier Jersey JE2 4UF |
Employees
Shareholders
| Mutual fund holders | 48.57% |
| Individual stakeholders | 35.99% |
| Other institutional | 25.75% |
Top Executives
| Asaf Danziger | Chief Executive Officer & Director |
| Wilco Groenhuysen | Chief Operating Officer |
| Ashley Cordova | Chief Financial Officer, SVP-Investor Relations |
| Uri Weinberg | Chief Science Officer |
| Ely Benaim | Chief Medical Officer |
